Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1167557 Greenwich, CT
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,661,092
-$2,370,945 QoQ
Shares Held
330,324
-29.5% QoQ
Ownership
0.263%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 271 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. ARQT ranks #60 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in ARQT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,661,092 330,324
2026-03-31 $11,032,037 468,253
2025-12-31 $14,503,096 499,418
2025-09-30 $8,318,786 441,315
2025-06-30 $5,260,765 375,233
2025-03-31 $3,881,784 248,196
2024-12-31 $2,848,405 204,480
2024-09-30 $2,345,003 252,151
2024-06-30 $2,393,419 257,357
2024-03-31 $308,189 31,099
2023-12-31 $933,754 289,088